Elevated plasma homocysteine levels in patients with isolated coronary artery ectasia

Coronary Artery Disease

Volumn 17, Issue 1, 2006, Pages 23-27

  Kosar, Feridun ^a,b   Sincer, Isa ^a   Aksoy, Yuksel ^a   Ozerol, Ibrahim ^a  

^a INONU UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Coronary artery ectasia; Homocysteine

Indexed keywords

HOMOCYSTEINE; BIOLOGICAL MARKER;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY ECTASIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; HYPERHOMOCYSTEINEMIA; LESIONS AND DEFECTS; MIDDLE AGED; PROGNOSIS; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR;

BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DILATATION, PATHOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33646980201     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200602000-00004     Document Type: Article

References (33)

1. Hartnell GG, Parnell BM, Pridie RB. Coronary artery ectasia, its prevalence and clinical significance in 4,993 patients. Br Heart J 1985; 54:392-395.
2. Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV, Gorlin R. Clinical significance of coronary artery ectasia. Am J Cardiol 1976; 37:217-222.
3. Falsetti HL, Carroll RJ. Coronary artery aneurysm. Chest 1976; 69:630-636.
4. Befeler B, Aranda JM, Embi A, Mullin FL, El-Sherif N, Lazzara R. Coronary artery aneurysms. Study of their etiology, clinical course and effect on left ventricular function and prognosis. Am J Med 1997; 62:597-607.
5. Williams MJ, Stewart RA. Coronary artery ectasia: local pathology or diffuse disease? Cathet Cardiovasc Diagn 1994; 33:116-119.
6. Swanton RH, Lea Thomas M, Coltard DJ, Jenkins BS, Webb-Peplow MM, Williams BT. Coronary artery ectasia, a variant of occlusive coronary arteriosclerosis. Br Heart J 1978; 40:393-400.
7. Papadakis MC, Manginas A, Cotileas P, Demopoulos V, Voudris V, Pavlides G, et al., Documentation of slow coronary flow by the TIMI frame count in patients with coronary ectasia. Am J Cardiol 2001; 88:1030-1032.
8. Akyurek O, Berkalp B, Sayin T, Kumbar D, Kervancioglu C, Oral D. Altered coronary flow properties in diffuse coronary artery ectasia. Am Heart J 2003; 145:66-72.
9. Senen K, Yetkin E, Turhan H, Atak R, Sivri N, Battaloglu B, et al. Increased thrombolysis in myocardial infarction frame counts in patients with isolated coronary artery ectasia. Heart Vessels 2004; 19:23-26.
10. Christensen B, Refsum H, Vintermyr O, Ueland PM. Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: methionine loading of nontrans-formed, transformed, proliferating and quiescent cells in culture. J Cell Biol 1991; 146:52-62.
11. Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF, et al. Homocysteine decrease bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997; 272:17012-17017.
12. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Harber E, Schlegel R, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994; 91:6369-6373.
13. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993; 91:308-318.
14. McCully KS. Homocysteine theory of arteriosclerosis. Atherosclerosis 1975; 22:215-227.
15. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338:1042-1050.
16. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999; 354:407-413.
17. MuCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56:111-122.
18. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999; 131:363-375.
19. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intake. JAMA 1995; 274:1049-1057.
20. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA 1997; 277:1775-1778.
21. Woo KS, Chook P, Lolin YI. Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 1997; 96:2542-2544.
22. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocysteinemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997; 95:1119-1121.
23. Chen Z, Li CS, Zhang J, Pang BS, Xia CQ, Liu XF. Relationship between endothelial dysfunction and serum homocysteine in patients with coronary lesions. Chin Med Sci J 2005; 20:63-66.
24. Vrentzos G, Papadakis JA, Malliaraki N, Zacharis EA, Katsogridakis K, Margioris AN, et al. Association of serum total homocysteine with the extent of ischemic heart disease in a Mediterranean cohort. Angiology 2004; 55:517-524.
25. Chao CL, Tsai HH, Lee CM. The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis. Atherosclerosis 1999; 147:379-386.
26. Schnyder G, Pin R, Roffi M, Flammer Y, Hess OM. Association of plasma homocysteine with the number of major coronary arteries severely narrowed. Am J Cardiol 2001; 88:1027-1230.
27. Schnyder G, Roffi M, Flammer Y, Pin R, Hess O. Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty. Eur Heart J 2002; 23:726-733.
28. Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation 2000; 102:2479-2483.
29. Title LM, Cummings PM, Giddens K, Genest JJ, Nassar BM. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol 2000; 36:758-765.
30. Woo KS, Chook P, Lolin YI, Sanderson JE, Metreweli C, Celermajer DS. Folic acid improves arterial endothelial function in adults with hyperhomocysteinemia. J Am Coll Cardiol 1999; 34:2002-2006.
31. Moghadasian MH, McManus MB, Frohlich JJ. Homocysteine and CAD. Arch Intern Med 1997; 157:2299-2308.
32. Jacques PF, Rasenberg IH, Rogers G, Selhub J, Bowman AB, Gunter EW, et al. Serum total homocysteine concentrations in adolescent and adult Americans: results from Third National Health and Nutrition Examination Survey. Am J Clin Nutr 1999; 69:482-489.
33. Refsum H, Smith D, Ueland PM, Nexo E, Clarke R, McPartlin J, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004; 50:3-32.